Morgan Stanley downgraded Affirm to Underweight from Equal Weight with a price target of $20, up from $15. Risk-reward appears skewed to the downside at current levels even with pending strength through a seasonally strong holiday period, and valuation seems difficult to justify across all metrics, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AFRM: